Resources with keywords: fungi
International risk assessment tool for Bacteria, Fungi, Viruses, and Parasites.
C. auris is the first fungal pathogen designated an urgent antimicrobial resistance threat. 6,304 U.S. clinical cases in 2024; estimated ~7,000 in 2025. C. auris persists on surfaces and medical equipment for weeks; HCWs involved in wound care, catheter insertion, and line management are at highest risk of pathogen carriage and inadvertent transmission. Clinical mycology laboratory personnel should use BSL-2 precautions. Environmental sampling of patient rooms is recommended. Echinocandin-resistant strains increasing; consult infectious disease specialist for treatment.
Approximately 95% of U.S. coccidioidomycosis (Valley fever) cases are reported from Arizona and California. Incidence of coccidioidomycosis in Arizona approximately doubled during 2005–2022.
Cavallone IN, et al.
Chromoblastomycosis (CBM) is a neglected, chronic subcutaneous disease with progressive development, caused by a variety of melanized fungal species, mainly Fonsecaea pedrosoi. We report a case of CBM in which Alternaria alternata was identified as the etiological agent in a patient with no history of immunodeficiency or other medical conditions that impair the immune response.
Kurutz A, Innes GK, Sherman A, et al.
Candida auris, a frequently multidrug-resistant fungal pathogen, can spread within health care facilities. Dialysis facilities face particular infection prevention and control (IPC) challenges because their patients require complex medical care and frequent invasive procedures.
Ghai RR, Sajewski ET, Blass M, et al.
Twelve members of an extended family developed mild-to-moderate histoplasmosis infections after touring the Venado Caves in Costa Rica.
Zucker J, Caplan AS, Gunaratne SH, et al.
5 cases diagnosed in NYC in summer 2024, previously not seen in the US.
International experts reach consensus on a set of descriptors to describe how pathogens are transmitted through the air and the related modes of transmission.
Cristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, Boni S, Pontali E
This pathogenic fungus shows an innate resilience, enabling survival and persistence in healthcare environment and the ability to rapidly colonize the patient’s skin and be easily transmitted within the healthcare setting, thus leading to a serious and prolonged outbreak.
